SLC9A1 and cyclic hematopoiesis: Previous reports have suggested that increased NHE1 activity is involved in the pathogenesis of cardiac pathologies [8] including CH [9, 10] and ischemia/reperfusion (I/R) injury [11] in both in vivo and in vitro models.